Maria Eliana Ruiz

Title: Maria Eliana Ruiz: Innovator in Immunotherapy

Introduction

Maria Eliana Ruiz is a prominent inventor based in Habana, Cuba. She has made significant contributions to the field of immunotherapy, particularly in the treatment of malignancies. Her innovative work focuses on targeting gangliosides, which are crucial in the development of effective cancer treatments.

Latest Patents

Maria Eliana Ruiz holds 1 patent for her invention titled "Anti ganglioside monoclonal antibodies." This invention relates to immunotherapy strategies aimed at treating malignancies by targeting gangliosides. Gangliosides are glycosphingolipids found on both normal and malignant cells, with a higher abundance and distinct organization on malignant cells. Her invention provides specific antibodies that recognize these gangliosides, which have recurrent idiotypes and serve as valuable immunoregulators. Additionally, the invention includes anti-idiotypic antibodies against anti-ganglioside antibodies, which can be utilized in vaccination strategies.

Career Highlights

Maria Eliana Ruiz is affiliated with the Centro de Inmunología Molecular, where she continues to advance her research and development in immunotherapy. Her work has the potential to significantly impact cancer treatment and improve patient outcomes.

Collaborations

Some of her notable coworkers include Ana Maria Lopez and Angel Mauro Fernandez, who contribute to her research efforts and the development of innovative therapies.

Conclusion

Maria Eliana Ruiz is a trailblazer in the field of immunotherapy, with her groundbreaking patent on anti-ganglioside monoclonal antibodies paving the way for new treatment strategies against malignancies. Her contributions are vital to the ongoing fight against cancer.